<DOC>
	<DOCNO>NCT01169116</DOCNO>
	<brief_summary>Patients single brain metastasis without metastatic site well prognosis , need good brain metastasis control . For non-resectable non-radiosurgical brain metastasis , gold standard treatment whole-brain irradiation 30 Gy 10 fraction , local control achieve case . This study investigate possibility increase radiation dose metastasis exclusive hypofractionated stereotactic radiotherapy .</brief_summary>
	<brief_title>Exclusive Hypofractionated Stereotactic Radiotherapy Non-resectable Single Brain Metastasis</brief_title>
	<detailed_description>For planning , patient undergo magnetic resonance imaging ( MRI ) 1.5 3 Tesla , contrast volumetric reconstruction 1 mm use MRI diagnosis metastasis , compatible planning system . Then , individualize mask Mask Set One Patient 41100 ( BrainLAB AG , Heimstetten , Germany ) patient . Patients undergo compute tomography ( CT ) without contrast 1-mm slice track stereotactic fixation . The image MRI CT fuse plan system IPLAN version 4.1 ( BrainLAB AG , Heimstetten , Germany ) , plan implement . The clinical target volume ( CTV ) macroscopic disease ( GTV ) display sign T1 contrast . The planning target volume ( PTV ) CTV 3-mm margin direction . Can use multiple dynamic arc , static conformal multiple field , multiple static field modulate multiple static arc . The dose-fractionation scheme 4 fraction 7 Gy periphery PTV , daily 4 consecutive working day . The dose PTV encompass area brainstem optic tract reduce 20 % . The plan standardize isocenter . The isodose prescription large isodose meet follow criterion : isodose cover least 95 % PTV prescription dose ( V100 ≥ 95 % ) 95 % prescription dose cover least 99 % PTV ( V95 ≥ 99 % ) . The maximum dose less 35 Gy . The dose constraint report Ernst-Stecken et al respect expense prescription isodose , normal brain volume ( total brain volume less volume PTV ) 20 cc receive dose 4 Gy per fraction large , maximum size limit metastasis include study . Use index compliance report Paddick et al Radiation Therapy Oncology Group ( RTOG ) . Tests do collision safety test quality control ensure alignment isocenters radiation , mechanical coincidence laser ( Winston-Lutz test ) . After , patient treat 6-MeV photon linear accelerator Varian Clinac 600 CD ( Varian Medical Systems , Palo Alto , CA , USA ) system `` micromultileaf '' m3 ( BrainLAB AG , Heimstetten , Germany ) .</detailed_description>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Neoplasms , Second Primary</mesh_term>
	<criteria>Histopathology primary tumor : primary characteristic melanoma cancer , small cell lung cancer , germ cell tumor , leukemia lymphoma , primary central nervous system . Primarysite : control , mean operate / irradiated tumor activity without detectable local Meningeal dissemination : none Extracranial metastasis : none Preirradiation brain : absent Number brain metastasis : one Location brain metastasis : brain region eligible surgery ( hippocampus , amygdala , motor area , eloquent cortex , thalamus , hypothalamus , basal ganglion , optic tract , midbrain , pons , medulla , corpus callosum internal capsule ) radiosurgery ( metastasis &lt; 5 mm thalamus , hypothalamus , basal ganglion , optic tract , midbrain , pons , medulla , corpus callosum internal capsule , / ≥ 10 ml ≥ 3 cm great diameter , 10 ml tissue receive ≥ 12 Gy ) . Karnofsky Performance Status ≥ 70 % Informed consent : authorized patient n't eligibility</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>radiotherapy</keyword>
	<keyword>radiation oncology</keyword>
	<keyword>brain metastasis</keyword>
	<keyword>metastasis</keyword>
	<keyword>radiosurgery</keyword>
	<keyword>neurosurgery</keyword>
	<keyword>hypofractionation</keyword>
	<keyword>stereotaxy</keyword>
</DOC>